This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Acinetobacter: NCBI 469, [genus]

Back to details

| Acinetobacter| Acinetobacter Brisou and Prevot 1954

  1. Hospital-Acquired Infections: Certain species of Acinetobacter, such as Acinetobacter baumannii, have been associated with healthcare-associated infections (HAIs). These bacteria can survive on surfaces and medical equipment and may cause infections in individuals with compromised immune systems, especially those in hospitals or other healthcare facilities.

  2. Antibiotic Resistance: Acinetobacter species are known for their ability to develop antibiotic resistance, making treatment challenging. Multi-drug resistant strains, including carbapenem-resistant Acinetobacter baumannii (CRAB), have become a significant concern in healthcare settings. This resistance can limit the available treatment options and contribute to the severity of infections.

  3. Types of Infections: Acinetobacter infections can manifest as pneumonia, bloodstream infections, urinary tract infections, and wound infections. Respiratory tract infections, especially ventilator-associated pneumonia, are commonly associated with Acinetobacter baumannii.

  4. Vulnerable Populations: Individuals at higher risk for Acinetobacter infections include those with compromised immune systems, severe underlying medical conditions, and those who have undergone invasive medical procedures or surgeries.

Other Sources for more information:

Legend

Acinetobacter impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart

Other bacteria of the same rank impacting Acinetobacter

R2SlopeTax NameParent Chart

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.217 ]